Table 3. Comparison of adverse events between the chemotherapy+CIK/DC-CIK and chemotherapy alone groups.
Adverse events | Chemo+CIK/DC-CIK | Chemo | Analysis method | Heterogeneity | Odds Ratio (OR) | 95% CI | P-value | |
---|---|---|---|---|---|---|---|---|
No. patients (n) | No. patients (n) | I2 (%) | P-value | |||||
Leucopenia | 412 | 384 | Random | 38 | 0.15 | 0.51 | 0.32 to 0.82 | 0.005 |
Leucopenia I | 339 | 312 | Random | 0 | 0.48 | 1.02 | 0.67 to 1.56 | 0.92 |
Leucopenia II | 339 | 312 | Random | 63 | 0.05 | 0.81 | 0.42 to 1.56 | 0.53 |
Leucopenia III | 339 | 312 | Random | 23 | 0.28 | 0.40 | 0.21 to 0.75 | 0.004 |
Leucopenia IV | 339 | 312 | Random | 0 | 1.00 | 0.55 | 0.26 to 1.19 | 0.13 |
Anemia | 382 | 354 | Random | 75 | 0.003 | 0.52 | 0.26 to 1.05 | 0.07 |
Anemia I | 339 | 312 | Random | 59 | 0.06 | 0.52 | 0.27 to 1.00 | 0.05 |
Anemia II | 339 | 312 | Random | 0 | 0.55 | 0.71 | 0.44 to 1.14 | 0.15 |
Anemia III | 339 | 312 | Random | 0 | 0.53 | 0.60 | 0.22 to 1.63 | 0.32 |
Anemia IV | 339 | 312 | Random | 0 | 0.68 | 0.45 | 0.13 to 1.51 | 0.19 |
Thrombocytopenia | 412 | 384 | Random | 63 | 0.02 | 0.54 | 0.29 to 0.99 | 0.05 |
Thrombocytopenia I | 339 | 312 | Random | 23 | 0.27 | 0.69 | 0.42 to 1.13 | 0.14 |
Thrombocytopenia II | 339 | 312 | Random | 55 | 0.08 | 0.76 | 0.35 to 1.69 | 0.50 |
Thrombocytopenia III | 339 | 312 | Random | 0 | 0.96 | 0.24 | 0.10 to 0.54 | 0.0006 |
Thrombocytopenia IV | 339 | 312 | Random | 0 | 0.88 | 0.90 | 0.22 to 3.63 | 0.88 |
Nausea, vomiting | 427 | 399 | Random | 65 | 0.009 | 0.55 | 0.31 to 0.98 | 0.04 |
Nausea, vomiting I | 339 | 312 | Random | 67 | 0.03 | 1.06 | 0.49 to 2.29 | 0.88 |
Nausea, vomiting II | 339 | 312 | Random | 0 | 0.86 | 0.61 | 0.42 to 0.89 | 0.01 |
Nausea, vomiting III | 339 | 312 | Random | 0 | 0.57 | 0.48 | 0.21 to 1.08 | 0.08 |
Nausea, vomiting IV | 339 | 312 | Random | 0 | 1.00 | 0.45 | 0.08 to 2.45 | 0.35 |
Liver dysfunction | 401 | 374 | Random | 0 | 0.44 | 0.55 | 0.38 to 0.80 | 0.002 |
Liver dysfunction I | 298 | 272 | Fixed | 0 | 0.96 | 0.59 | 0.33 to 1.06 | 0.08 |
Liver dysfunction II | 298 | 272 | Fixed | 0 | 0.57 | 0.52 | 0.31 to 0.88 | 0.01 |
Liver dysfunction III | 298 | 272 | Fixed | 36 | 0.21 | 0.90 | 0.26 to 3.14 | 0.87 |
Liver dysfunction IV | 298 | 272 | Fixed | 0 | 0.47 | 0.53 | 0.13 to 2.26 | 0.39 |
Myelosuppression | 159 | 159 | Random | 0 | 0.90 | 0.21 | 0.11 to 0.39 | < 0.00001 |
Peripheral neurotoxicity | 196 | 195 | Random | 0 | 0.42 | 0.31 | 0.18 to 0.55 | < 0.00001 |
Gastrointestinal AE | 153 | 152 | Random | 0 | 0.53 | 0.26 | 0.15 to 0.45 | < 0.00001 |
AE: adverse reaction.